Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
about
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingEnteric microbiota leads to new therapeutic strategies for ulcerative colitis.Effects of bowel cleansing on the intestinal microbiota.Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapyDevelopment of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.Volume-sensitive outwardly rectifying Cl(-) channels contribute to butyrate-triggered apoptosis of murine colonic epithelial MCE301 cells.Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative ColitisCITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitisIdentification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene.The role of bacteria in the pathogenesis of ulcerative colitisAdjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial.Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium?Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium? Authors' reply.Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.and Colorectal Cancer
P2860
Q34110225-09193507-948B-41F0-9A46-E2E45698554AQ34499080-F97BC902-9AED-463E-8C81-533C8BD01BE5Q35531348-F083F88B-62E8-45F4-B612-758D45BDDC75Q36160305-B1EC35CC-A8B3-4869-B8FB-19BD24105C7EQ37529381-539B0113-41DC-40EC-9AF0-5D2F9DF0AF71Q38011771-4F15DACB-5088-4619-8FE7-B34EF471B3C0Q38924973-5D6F2C50-516C-4A66-B562-5F0692FBC26FQ39424570-55380FD4-826B-4F32-91CF-974EB09DB85CQ39619078-551AB19B-0196-4B56-9DFD-94603AC4C31BQ39860570-025F03DB-D81D-4BF6-A9C2-B7618D5405ACQ40423682-B53F3251-0900-4DCF-B3DC-688F12EE6F29Q41860050-ED250661-93F3-4E0D-B813-95EA49ACC2DBQ42648367-109B7378-D6A9-4BE3-9185-F408A2DA716AQ43136343-7604AEE2-BFD1-40B9-A710-69D6E360CB1DQ43598319-13AD1B2D-8AC2-45FF-A434-15A654BEDE4AQ44488826-A220F1F3-DDE9-4DFB-A589-A6BA699369B6Q44544446-1B9DFDDF-5A06-4A1D-B110-2CAAB53D4C33Q45378594-3ED575CE-DD2D-47C6-8C08-77A20EF2985FQ46339795-E3BD9B33-1F2B-4123-BE29-F4E55EFC62B1Q58122181-D23F670E-8AB2-453B-8983-E97A385D3AB3
P2860
Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@en
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@nl
type
label
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@en
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@nl
prefLabel
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@en
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@nl
P2093
P2860
P1476
Mucosa-associated bacteria in ...... ntibiotic combination therapy.
@en
P2093
Kobayashi O
P2860
P304
P356
10.1111/J.1365-2036.2005.02428.X
P407
P577
2005-04-01T00:00:00Z